asa glp-1 agonists The 2023 position on receptor has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on A narrative review of glucagon-like
Description
(2009) 296:E41521
Brain abbreviations are as follows: NAc, nucleus accumbens
More than neuron, liraglutide alleviates mitochondrial dysfunction in astrocytes through the cAMP/PKA signaling pathway, and it enhances the neuronal supportive capacity of astrocytes treated with A [80]
Possible side effects GLP-1 receptor agonists can cause side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain
GLP-Medikamente wurden mit dem Ziel entwickelt, die Blutzuckerregulierung zu untersttzen und damit den Alltag von Diabetes-Patienten leichter zu machen
Disclosure Dr Doundoulakis, Dr Antza, and Dr Toulis report no conflicts of interest in this work
